Institute of Medical Genetics and Pathology, Division of Neuropathology, University Hospital Basel, Basel, Switzerland.
Institute of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Eur J Cancer. 2023 Jul;187:7-14. doi: 10.1016/j.ejca.2023.03.032. Epub 2023 Apr 2.
Dedifferentiated melanoma (DedM) poses significant diagnostic challenges. We aimed to investigate the clinical, histopathological and molecular features of DedM. Methylation signature (MS) and copy number profiling (CNP) were carried out in a subgroup of cases.
A retrospective series of 78 DedM tissue samples from 61 patients retrieved from EORTC (European Organisation for Research and Treatment of Cancer) Melanoma Group centres were centrally reviewed. Clinical and histopathological features were retrieved. In a subgroup of patients, genotyping through Infinium Methylation microarray and CNP analysis was carried out.
Most patients (60/61) had a metastatic DedM showing most frequently an unclassified pleomorphic, spindle cell, or small round cell morphology akin to undifferentiated soft tissue sarcoma, rarely associated with heterologous elements. Overall, among 20 successfully analysed tissue samples from 16 patients, we found retained melanoma-like MS in only 7 tissue samples while a non-melanoma-like MS was observed in 13 tissue samples. In two patients from whom multiple specimens were analysed, some of the samples had a preserved cutaneous melanoma MS while other specimens exhibited an epigenetic shift towards a mesenchymal/sarcoma-like profile, matching the histological features. In these two patients, CNP was largely identical across all analysed specimens, in line with their common clonal origin, despite significant modification of their epigenome.
Our study further highlights that DedM represents a real diagnostic challenge. While MS and genomic CNP may help pathologists to diagnose DedM, we provide proof-of-concept that dedifferentiation in melanoma is frequently associated with epigenetic modifications.
去分化黑色素瘤(DedM)带来了重大的诊断挑战。我们旨在研究 DedM 的临床、组织病理学和分子特征。在部分病例中进行了甲基化特征(MS)和拷贝数谱分析(CNP)。
从欧洲癌症研究与治疗组织(EORTC)黑色素瘤组中心回顾性收集了 61 例 78 例 DedM 组织样本,这些样本来自 61 例患者。回顾了临床和组织病理学特征。在部分患者中,通过 Infinium 甲基化微阵列和 CNP 分析进行了基因分型。
大多数患者(60/61)患有转移性 DedM,最常见的是未分类的多形性、梭形细胞或小圆细胞形态,类似于未分化的软组织肉瘤,很少伴有异源性成分。总的来说,在 16 例患者的 20 例成功分析的组织样本中,我们仅在 7 例组织样本中发现保留了黑色素瘤样 MS,而在 13 例组织样本中观察到非黑色素瘤样 MS。在 2 例来自多个标本的患者中,一些标本保留了皮肤黑色素瘤 MS,而其他标本表现出向间充质/肉瘤样表型的表观遗传转变,与组织学特征相匹配。在这两个患者中,尽管他们的表观基因组发生了显著改变,但 CNP 在所有分析的标本中基本相同,这符合他们的共同克隆起源。
我们的研究进一步强调,DedM 确实是一个诊断挑战。虽然 MS 和基因组 CNP 可能有助于病理学家诊断 DedM,但我们提供了证据表明黑色素瘤的去分化通常与表观遗传改变有关。